Retour à toutes les opportunités
ItalieTechnology Offer

Italian neurorehabilitation centre experienced in national and EU research projects seeks to join or coordinate consortia for Horizon Europe Health calls: HORIZON-HLTH-2027-02-DISEASE-14, HORIZON-HLTH-2027-01-STAYHLTH-01 and HORIZON-HLTH-2027-02-TOOL-01.

Résumé de l'Opportunité

The Italian neurorehabilitation centre, authorised to conduct phase II and III drug trials, seeks to join or coordinate European collaborative projects in neuroscience and translational clinical research. It can contribute with patient recruitment, clinical trials and biomarker validation and analysis. The centre is equipped with: 3 Tesla magnetic resonance imaging, Biobank - BBMRI, Motion Lab Analysis, and Neurophysiological assessment.

Description de l'Opportunité

Italian multi-specialty health centre (in-patient and out-patient) specialised in neurorehabilitation, with a dedicated research department, classified as a large enterprise for European funding purposes. Care and rehabilitation go together with clinical and translational research on neurological and neurodegenerative diseases. THE R&D PROJECTS The centre wishes to join, as clinical partner, consortia preparing proposals for the Horizon Europe Health two-stage 2027 call, in particular HORIZON-HLTH-2027-02-DISEASE-14-two-stage (clinical trials of innovative interventions for neurodegenerative diseases) and HORIZON-HLTH-2027-02-TOOL-01-two-stage (artificial intelligence, AI, to develop predictive biomarkers of disease progression and treatment response in chronic non-communicable diseases). Other European collaborative health research calls are also of interest. THE CHALLENGE Projects on neurodegenerative diseases need clinical partners able to recruit patients and contribute to biomarker studies, neuroimaging and clinical validation. THE CONTRIBUTION Thanks to its structure, the multi-specialty health centre brings together neurological care, rehabilitation, imaging, laboratory research and biobanking within a single organisation, enabling that patients, data and biological samples can be linked directly: • Patient recruitment. About 1,000 neurological inpatients per year, mainly with multiple sclerosis, stroke and spinal cord injury, hospitalised for 2-6 months and assessed with standardised clinical scales. Parkinson's disease is a smaller share of admissions but a key research area, with ongoing European projects on biomarkers. • Clinical studies. Authorised to conduct phase II and III interventional drug trials and already a clinical site in pharmacological studies. • Biological samples and biomarkers. An institutional biobank, part of national and European biobanking initiatives. The neurobiology laboratory has experience in blood fraction processing, extracellular vesicles (including neuronal-derived ones) and ultrasensitive single-molecule biomarker analysis (SIMOA), with current research on alpha-synuclein-related biomarkers in Parkinson's disease and synaptic proteins linked to disease severity. • Imaging and neuromodulation. A 3 Tesla magnetic resonance imaging (MRI) facility and expertise in non-invasive brain stimulation (transcranial direct current stimulation, tDCS). • Functional assessment and technology validation. Gait and movement analysis (motion capture, force platforms, wearable sensors) and a Living Lab reproducing a home environment, to test rehabilitation and assistive technologies in everyday-life conditions. • Multidisciplinary assessment. Neurological, neuropsychological, functional and rehabilitation assessments can be integrated according to the needs of the study protocol. EXPERIENCE Numerous European and national projects. A dedicated Grants Office and project management team covers proposal preparation, work-package management and technical and financial reporting, with significant experience in lump-sum funded projects. WHY A RESEARCH AND DEVELOPMENT COOPERATION The centre would cooperate from the proposal-development under a research and development cooperation agreement, co-defining with partners and coordinator clinical activities, patient population, recruitment strategy, endpoints, sampling and imaging requirements, validation activities, work-package responsibilities and resources. The exact role and effort will be agreed during proposal preparation. For suitable calls the centre is also available to coordinate the consortium. Coordinators, consortia and complementary partners (therapy developers, AI and data science, biomarker and imaging technologies) are welcome.

Partenaire Recherché

The centre is interested in establishing research and development cooperation with partners and consortia preparing European collaborative research projects in neurological and neurodegenerative diseases and related areas. Particular interest is given to collaborations relevant to HORIZON-HLTH-2027-02-DISEASE-14-two-stage and HORIZON-HLTH-2027-02-TOOL-01-two-stage, while other Horizon Europe and European collaborative health research opportunities are also of interest. Different project concepts and potential collaborations are welcome where the clinical and research expertise described above could contribute, either fully or in part, to the proposed activities.

Coopération Attendue

  • Accord de coopération en recherche et développement

Mots-clés Secteur / Marché

  • Other clinical medicine
  • Réhabilitation et formation des patients
  • Diagnostic services
  • Therapeutic services
  • Autres médical/ santé liés (non classés ailleurs)
  • Recherche médicale
  • Diagnostics, Diagnosis
  • Recherche clinique, essais
  • Neurology, Brain Research

Opportunités Similaires

Italie
Nouveau

An Italian digital health company is seeking partners and representative organisations from the health and tech sectors for a Horizon Europe Cluster 1 proposal focused on assistive technologies supporting the daily independence of people with disabilities.

An Italian digital health company (IT group), which is coordinating a Horizon Europe Cluster 1 proposal (topic STAYHLTH-01) on assistive technology and AI for the daily independence of people with visual, intellectual and mental disabilities, validated in sport settings, is seeking: - organisations of persons with disabilities, - social science groups, - experts in embedded vision and spatial audio, - neuropsychiatry and mental health services.

R&D RequestLogiciels médicaux/santéMedical computer sciences
Publication
19/11/2026
Validité
19/11/2027
Réf EEN
RDRIT20261119027
Italie
Nouveau

An Italian Digital Health company seeks end-users and research partners from other UNITE regions for a UNITE Open Call 2 proposal focused on an AI-powered solution that helps automating patient follow-up for diabetes care.

An Italian Digital Health company from Lombardy (Italy), part of an IT group, is preparing a UNITE Open Call 2 proposal (challenge "Digital innovation to battle the health workforce crisis") on an AI layer that automates recall, booking, bundling and patient reminders for diabetes follow-up. The company is seeking an end user (diabetes service, health board or primary care) and a research organisation from one of the UNITE regions, ideally Scotland or Wales.

R&D RequestAutres médical/ santé liés (non classés ailleurs)Hospital and other institutional management
Publication
17/11/2026
Validité
17/11/2027
Réf EEN
RDRIT20261117008
Italie

Italian manufacturer of food processing, dosing and packaging machinery seeks international distributors, commercial agents and customers under commercial agreement

An Italian SME specialised in the design and manufacture of industrial machinery for the agri-food sector is seeking international distributors, commercial agents and direct customers under commercial agreement. The company offers individual machines, modular equipment and turnkey production lines for fruit and vegetable processing, food preparation, dosing, filling and packaging.

Business OfferOutils de machine, autres équipements de travail des métaux (hors contrôle numérique)Autre équipement et machines industriels
Publication
13/11/2026
Validité
13/11/2027
Réf EEN
BOIT20261113006